WC
NTLA icon

Woodstock Corp’s Intellia Therapeutics NTLA Stock Holding History

Woodstock Corp’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,550
Closed -$525K – 160
2024
Q3 		$525K Buy
25,550
+12,938
+103% +$298K 0.05% 121
2024
Q2 		$282K Buy
+12,612
New +$300K 0.03% 142
2023
Q4 		– Sell
-9,002
Closed -$285K – 170
2023
Q3 		$285K Hold
9,002
– – 0.04% 139
2023
Q2 		$367K Hold
9,002
– – 0.04% 136
2023
Q1 		$336K Hold
9,002
– – 0.04% 138
2022
Q4 		$314K Buy
9,002
+3,821
+74% +$182K 0.04% 140
2022
Q3 		$290K Buy
+5,181
New +$321K 0.04% 137

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Woodstock Corp's NTLA Position: Q4 2024 in Review

Woodstock Corp sold out of Intellia Therapeutics (NTLA) in Q4 2024, closing a stake of 25,550 shares — an estimated $525K sold.

Woodstock Corp first reported a position in NTLA in Q3 2022 and held it in 7 quarters. The position peaked at $525K in Q3 2024. 295 funds tracked by Wall St. Rank hold NTLA as of Q4 2024.

  • Woodstock Corp reported no remaining Intellia Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Woodstock Corp sold 25,550 Intellia Therapeutics shares in Q4 2024, an estimated $525K.
  • Woodstock Corp first reported a position in Intellia Therapeutics in Q3 2022 and held it in 7 quarters.
  • Woodstock Corp's Intellia Therapeutics position peaked at $525K in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2024.

Based on Woodstock Corp's 13F filing for Q4 2024, filed 15 Jan 2025.